12 Weeks of Water Aerobics at Various Intensities for Adults and Older Adults

NCT06509217 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2024-07-19

No results posted yet for this study

Summary

The objective of this clinical trial is to understand the best intensity to perform water aerobics with adults and older adults. The main questions it aims to answer are:

* Is water aerobics performed at high intensity better than water aerobics performed at moderate intensity?
* Is performing water aerobics for 12 weeks good for muscle strength, body composition (body weight, fat mass), lipid profile (triglycerides, cholesterol), blood pressure, and quality of life in adults and older adults?

Participants need:

* Perform water aerobics at high or moderate intensity, twice a week, 45 minutes per class, for 12 weeks
* Be evaluated in the week before starting the water aerobics program (week 0) and at the end week of the program (week 12) regarding muscle strength, body composition, lipid profile, blood pressure, and quality of life

It was hypothesized that independently of the level of intensity used, all variables would improve after water aerobics. It was also expected to observe more gains in all parameters in high-intensity water aerobics compared to moderate intensity

Conditions

  • Healthy

Interventions

BEHAVIORAL

Moderate-intensity Group

Water aerobics sessions involved exercises performed at a moderate intensity, between 60% and 70% of the participant's maximum heart rate predicted by their age.

BEHAVIORAL

High-intensity Group

Water aerobics sessions involved exercises performed at a high intensity, between 80% and 90% of the participant's maximum heart rate predicted by their age.

Sponsors & Collaborators

  • Luís Oliveira Brandão Faíl

    lead OTHER

Principal Investigators

  • Luís Faíl · University of Beira Interior

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-19
Primary Completion
2022-12-16
Completion
2022-12-23

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06509217 on ClinicalTrials.gov